Financial Summary for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

Performance Overview

For the fiscal year ending March 2026, consolidated net sales were 579.629 billion yen (down 1.2% YoY), operating income was 42.069 billion yen (down 31.0% YoY), and ordinary income was 45.130 billion yen (down 27.6% YoY). Net income attributable to owners of parent decreased to 10.180 billion yen (down 79.4% YoY), mainly due to impairment losses resulting from delayed demand expansion for the COC resin new plant and increased investment costs. Segment-wise, the Medical & Healthcare and Safety businesses experienced increased sales and profit, while Smart and Material businesses saw decreased sales and profit.

Financial Position and Cash Flows

Total assets increased by 20.098 billion yen from the previous fiscal year-end to 833.929 billion yen, and net assets reached 370.380 billion yen, with an equity ratio of 42.6%. Cash flows from operating activities increased by 67.838 billion yen, while cash flows used in investing activities decreased by 47.72 billion yen, and cash flows used in financing activities decreased by 22.814 billion yen. The ending balance of cash and cash equivalents was 66.830 billion yen.

Dividends and Earnings Guidance

Annual dividends are maintained at 30 yen (interim 30 yen, year-end 30 yen), with a payout ratio of 154.8%. The consolidated forecasts for FY2027 project net sales of 595.0 billion yen (up 2.7% YoY), operating income of 42.5 billion yen (up 1.0% YoY), and net income attributable to owners of parent of 32.0 billion yen (up 214.3% YoY). Despite rising raw material prices and intensified competition, increased sales are expected in the Engineering Plastics and automotive airbag inflator segments.